---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Skeletal muscle relaxants]]"
DrugClassContra: "[[Skeletal muscle relaxants#Contraindications]]"
DrugClassAdverse: "[[Skeletal muscle relaxants#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Dantrium
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Spasticity caused by [[Spinal cord]] injury, stroke, cerebral palsy, multiple sclerosis
Initial dose: 25 mg/ day orally, then 50â€“ 400 mg/ day orally in divided doses

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Drowsiness, dizziness, weakness, constipation, tachycardia, malaise

### Interactions

`= this.ChemLink+this.file.name`

